Back to search

Peptide record

TPDB42863

RF13 Anticancer standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB42863
RF13
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 13-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
RRGKGGRRVTMSF
Physicochemical Analysis
C62H110N26O16S1
ANDCEQHILPWY
R
1507.78
12.88
5
0
3
+5
3.24
-1.208
22.31
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
0
0.00
2
Residue Composition
number
0
A
4
R
0
N
0
D
0
C
0
E
0
Q
3
G
0
H
0
I
0
L
1
K
1
M
1
F
0
P
1
S
1
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 0 R: 4 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 3 H: 0 I: 0 L: 0 K: 1 M: 1 F: 1 P: 0 S: 1 T: 1 W: 0 Y: 0 V: 1
Chemical Descriptors
13
C62H110N26O16S1
1507.78
12.88
+5
3.24
-1.208
Free
L
Linear
Free
Anticancer
VSP26B of C. striatus
Evidence Records 1 records
Evidence 1 Activity

Activity

IC50
IC50 = 49.65 µM
Anticancer
49.65 µM

Target

Larynx Cancer
HEp-2
Larynx

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2022

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.